Fluorodopa F 18: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

17 March 2025

  • curprev 14:5814:58, 17 March 2025 Omid Afkhami-Ardakani talk contribs 4,778 bytes +4,778 Created page with "{{DrugProjectFormSinglePage |authorTag=Omid Afkhami-Ardakani |genericName=fluorodopa F 18 |aOrAn=a |drugClass=Radiopharmaceutical Diagnostic Agent |indication=indicated for use in positron emission tomography (PET) to visualize dopaminergic nerve terminals in the striatum for the evaluation of adult patients with suspected Parkinsonian syndromes (PS). |adverseReactions=Injection site pain |blackBoxWarningTitle='''<span style="color:#FF0000;">TITLE</span>''' |blackBoxWarn..."